Table 2.
Correlations Between circPTK2 Expression and Clinical Characteristics in 90 Patients.
| Clinical characteristics | hsa_circ_0005982 |
|
|---|---|---|
| r | P | |
| Age | 0.181 | 0.087 |
| BMI | -0.526∗ | 0.001∗ |
| WL | 0.504 | 0.001∗ |
| HB | -0.127 | 0.233 |
| WBC | 0.031 | 0.773 |
| PLT | -0.192 | 0.069 |
| Alb | -0.301 | 0.063 |
| PAb | -0.635∗ | <0.001∗ |
| TC | -0.240 | 0.098 |
| TG | -0.064 | 0.547 |
| LDL | -0.118 | 0.269 |
| HDL | -0.179 | 0.092 |
| FFA | 0.604∗ | <0.001∗ |
| ApoA | -0.305 | 0.204 |
| ApoB | -0.032 | 0.765 |
| ApoE | -0.655∗ | 0.012∗ |
| TNFα | 0.366 | 0.015 |
| IL6 | 0.712∗ | <0.001∗ |
BMI Body mass index, WL Weight loss, HB Hemoglobin, WBC White blood cell count, PLT Platelet, Alb Albumin, PAb Prealbumin, TC Total cholesterol, TG Tri-glyceride, LDL Low-density lipoprotein, HDL High-density lipoprotein, ApoA Apolipoprotein A, ApoB Apolipoprotein B, ApoE Apolipoprotein E, FFA Free fatty acid, IL-6 Interleukin 6, TNF-α Tumor Necrosis Factor-α.